Sun Pharma Advanced Research Co. Ltd. NSE:SPARC

Press Release Nov 09 2022

Published November 9, 2022 at 4:52 p.m. UTC

Sun Pharma Advanced Research Company Limited has informed the Exchange about press release dated 09-Nov-2022 titled SPARC and Sun Pharma enter into a license agreement for commercialization of phenobarbital for injection in the US

View Attachment